{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/62332-234#drug","name":"VILAZODONE HYDROCHLORIDE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"62332-234"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA208202"},{"@type":"PropertyValue","propertyID":"UNII","value":"U8HTX2GK8J"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"8b95b850-8bdf-4255-a691-783d1a94bd07"}],"activeIngredient":"VILAZODONE HYDROCHLORIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"Alembic Pharmaceuticals Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/ANDA208202","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b95b850-8bdf-4255-a691-783d1a94bd07","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-234"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-28T03:39:47.026Z"}}